Healthcare - Biotechnology - NASDAQ - US
$ 1.1299
-0.886 %
$ 33.4 M
Market Cap
-4.18
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
37.74%
EBIT
Estimate
18.25%
Net Income
Estimate
--16.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dyadic International, Inc.
DYAI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart DYAI
EBIT FORECAST
EBIT Forecast Chart DYAI
NET INCOME FORECAST
Net Income Chart DYAI